The Human Rights (Parliamentary Security) Act 2011 (Cth) and the Increasingly Visible Intersections between the Human Right to Health and Intellectual Property in Australia

Wilkinson, GM

The Human Rights (Parliamentary Security) Act 2011 (Cth) and the Increasingly Visible Intersections between the Human Right to Health and Intellectual Property in Australia

Wilkinson, GM

Permalink

Publication Type:: Journal Article
Citation:: Intellectual Property Forum, 2016, (105), pp. 46 - 54
Issue Date:: 2016-06

Closed Access

	Filename	Description	Size
	IntProFor2016N105_046.pdf	Published Version	114.79 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Wilkinson, GM https://orcid.org/0000-0002-4946-5437	en_US
dc.date.issued	2016-06	en_US
dc.identifier.citation	Intellectual Property Forum, 2016, (105), pp. 46 - 54	en_US
dc.identifier.issn	0815-2098	en_US
dc.identifier.uri	http://hdl.handle.net/10453/118678
dc.description.abstract	Health and intellectual property intersect in many ways. Patent, trade mark and copyright legislation provide limited monopolies as incentives for innovation and creation. This can encourage the development of new pharmaceuticals and diagnostic methods which address disease and illness. However these monopolies can often restrict or prevent public access to those pharmaceuticals or diagnostic methods and the copyright works that describe and analyse them. These restrictions can negatively impact on health outcomes for individuals and populations.	en_US
dc.relation.ispartof	Intellectual Property Forum	en_US
dc.title	The Human Rights (Parliamentary Security) Act 2011 (Cth) and the Increasingly Visible Intersections between the Human Right to Health and Intellectual Property in Australia	en_US
dc.type	Journal Article
utslib.citation.volume	105	en_US
utslib.location.activity	Australia	en_US
utslib.for	1801 Law	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Law
utslib.copyright.status	closed_access
pubs.consider-herdc	true	en_US
pubs.issue	105	en_US
pubs.publication-status	Published	en_US

Abstract:

Health and intellectual property intersect in many ways. Patent, trade mark and copyright legislation provide limited monopolies as incentives for innovation and creation. This can encourage the development of new pharmaceuticals and diagnostic methods which address disease and illness. However these monopolies can often restrict or prevent public access to those pharmaceuticals or diagnostic methods and the copyright works that describe and analyse them. These restrictions can negatively impact on health outcomes for individuals and populations.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/118678